Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 USD | +5.41% | +0.91% | +24.50% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 39.57 | 26.82 | 39.65 | 52.83 | 51.79 | 26.8 |
Enterprise Value (EV) 1 | 41.2 | 26.99 | 39.36 | 31.42 | 32.78 | 14.86 |
P/E ratio | 58 x | -7.14 x | -11.3 x | -471 x | 136 x | -4.15 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 4.38 x | 3.24 x | 7.57 x | 6.82 x | 4.69 x | 3.08 x |
EV / Revenue | 4.56 x | 3.26 x | 7.52 x | 4.06 x | 2.97 x | 1.71 x |
EV / EBITDA | -55.5 x | -18.8 x | -18.8 x | 104 x | 25.7 x | -2.68 x |
EV / FCF | -24.1 x | 26.1 x | -105 x | -9.26 x | -40.4 x | -2.65 x |
FCF Yield | -4.15% | 3.83% | -0.96% | -10.8% | -2.48% | -37.7% |
Price to Book | 3.47 x | 3.18 x | 5.54 x | 1.64 x | 1.62 x | 1.05 x |
Nbr of stocks (in thousands) | 68,227 | 69,661 | 75,950 | 106,118 | 106,373 | 107,647 |
Reference price 2 | 0.5800 | 0.3850 | 0.5220 | 0.4978 | 0.4869 | 0.2490 |
Announcement Date | 4/1/19 | 4/14/20 | 3/31/21 | 3/31/22 | 7/18/23 | 4/12/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 9.034 | 8.268 | 5.236 | 7.748 | 11.04 | 8.693 |
EBITDA 1 | -0.742 | -1.432 | -2.093 | 0.3018 | 1.275 | -5.553 |
EBIT 1 | -1.653 | -3.745 | -3.305 | -0.586 | 0.3482 | -6.851 |
Operating Margin | -18.3% | -45.3% | -63.12% | -7.56% | 3.15% | -78.81% |
Earnings before Tax (EBT) 1 | 0.5409 | -3.673 | -3.287 | -0.0605 | 0.4447 | -6.348 |
Net income 1 | 0.8732 | -3.673 | -3.287 | -0.0605 | 0.4287 | -6.348 |
Net margin | 9.67% | -44.42% | -62.78% | -0.78% | 3.88% | -73.03% |
EPS 2 | 0.009999 | -0.0539 | -0.0460 | -0.001056 | 0.003588 | -0.0600 |
Free Cash Flow 1 | -1.709 | 1.035 | -0.3765 | -3.393 | -0.8121 | -5.599 |
FCF margin | -18.92% | 12.52% | -7.19% | -43.8% | -7.35% | -64.41% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/1/19 | 4/14/20 | 3/31/21 | 3/31/22 | 7/18/23 | 4/12/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.62 | 0.17 | - | - | - | - |
Net Cash position 1 | - | - | 0.29 | 21.4 | 19 | 11.9 |
Leverage (Debt/EBITDA) | -2.189 x | -0.1217 x | - | - | - | - |
Free Cash Flow 1 | -1.71 | 1.04 | -0.38 | -3.39 | -0.81 | -5.6 |
ROE (net income / shareholders' equity) | 8.01% | -36.9% | -42% | -0.31% | 1.33% | -22.1% |
ROA (Net income/ Total Assets) | -5.96% | -15% | -15.3% | -1.52% | 0.62% | -13.6% |
Assets 1 | -14.66 | 24.52 | 21.48 | 3.988 | 68.65 | 46.55 |
Book Value Per Share 2 | 0.1700 | 0.1200 | 0.0900 | 0.3000 | 0.3000 | 0.2400 |
Cash Flow per Share 2 | 0 | 0 | 0.0100 | 0.2000 | 0.1800 | 0.1100 |
Capex 1 | 0.9 | 0.79 | 0.24 | 0.65 | 1.73 | 1.53 |
Capex / Sales | 9.95% | 9.59% | 4.64% | 8.37% | 15.63% | 17.58% |
Announcement Date | 4/1/19 | 4/14/20 | 3/31/21 | 3/31/22 | 7/18/23 | 4/12/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+24.50% | 33.62M | |
+35.24% | 89.99B | |
+20.46% | 73.66B | |
-.--% | 29.09B | |
+46.56% | 9.69B | |
+12.53% | 9.35B | |
+21.50% | 8.98B | |
+8.63% | 8.15B | |
+30.76% | 6.13B | |
-32.59% | 6.3B |
- Stock Market
- Equities
- UAMY Stock
- Financials United States Antimony Corporation